SCHEMBL1710592

SCHEMBL1710592

CCCC1(CCC)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28282096 0.97
SCHEMBL28281978 0.89
SCHEMBL7054256 0.88
SCHEMBL15187187 0.87
Dimethyl Sulfoxide SCHEMBL10480705 0.87
SCHEMBL10870786 0.84 SIRT2 (0.39)
SCHEMBL10869899 0.84 SIRT2 (0.39)
SCHEMBL10873955 0.84 SIRT2 (0.39)
SCHEMBL10870865 0.84 SIRT2 (0.39)
SCHEMBL10871122 0.84 SIRT2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029708-B2 Alkoxy compounds for disease treatment ACUCELA INC. (US) 2024-07-09 US disclosed
US-12029708-B2 Alkoxy compounds for disease treatment ACUCELA INC. (US) 2024-07-09 US disclosed
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2023-07-13 US disclosed
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2023-07-13 US disclosed
US-11446261-B2 Alkoxy compounds for disease treatment ACUCELA INC. (US) 2022-09-20 US disclosed
US-20210077427-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2021-03-18 US disclosed
US-10639286-B2 Alkoxy compounds for disease treatment ACUCELA INC. (US) 2020-05-05 US disclosed
US-20190183816-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2019-06-20 US disclosed
US-10188615-B2 Alkoxy compounds for disease treatment ACUCELA INC. (US) 2019-01-29 US disclosed
US-20180177746-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2018-06-28 US disclosed
EP-0310321-B1 Immunomodulatory azaspiranes SMITHKLINE BEECHAM CORP (US) 1994-11-30 EP disclosed
WO-1989002889-A1 IMMUNOMODULATORY AZASPIRANES SMITHKLINE BECKMAN CORPORATION (US) 1989-04-06 WO disclosed
EP-0310321-A2 Immunomodulatory azaspiranes SMITHKLINE BEECHAM CORPORATION (US) 1989-04-05 EP disclosed
US-4503204-A CATALYST CONTAINING ALUMINUM, MAGENESIUM AND BARIUM, STRONTIUM OR CALCIUM THE GENERAL TIRE & RUBBER COMPANY (US) 1985-03-05 US disclosed
US-4355156-A ALCOHOLATE CATALYST COMPONENT THE GENERAL TIRE & RUBBER COMPANY (US) 1982-10-19 US disclosed
US-4307218-A TRANS- POLYBUTADIENE OR BUTADIENE- STYRENE COPOLYMER THE GENERAL TIRE & RUBBER COMPANY (US) 1981-12-22 US disclosed
US-4302568-A POLYMERIZATION CATALYST COMPRISING A COMPLEX OF A GROUP 2A METAL ALCOHOLATE AND ALUMINUM AND MAGNESIUM COMPOUNDS THE GENERAL TIRE & RUBBER CO. (US) 1981-11-24 US disclosed
US-4297240-A AND A POLYMERIZATION CATALYST MADE FROM ALKALINE METAL ALCOHOLATES AND ALKYL OR CYCLOALKYL ALUMINUM AND MAGNESIUM COMPOUNDS THE GENERAL TIRE & RUBBER COMPANY (US) 1981-10-27 US disclosed
US-4260519-A POLYMERIZATION CATALYSTS THE GENERAL TIRE & RUBBER COMPANY (US) 1981-04-07 US disclosed
US-4260712-A USED IN COMPLEXES WITH A HYDROCARBYL LITHIUM COMPOUND AS A POLYMERIZATION CATALYST THE GENERAL TIRE & RUBBER COMPANY (US) 1981-04-07 US disclosed